Katherine Ruffner

Katherine Ruffner

Plus aucun poste en cours
Health Technology
Consumer Services

Profil

Katherine L.
Ruffner
worked as a Senior Director of Clinical Development at Seagen Inc. She was the Vice President of Clinical Development at CTI BioPharma Corp from 2008 to 2019.
Prior to that, she was an Assistant Professor at Vanderbilt University from 2002 to 2007.
She also worked as the Vice President of Clinical Development at ALX Oncology Holdings, Inc. from 2020 to 2021 and as the Chief Medical Officer at Cardiff Oncology, Inc. in 2021 to 2022.
Ruffner received her undergraduate degree from Duke University and her graduate degree from the University of Tennessee.

Anciens postes connus de Katherine Ruffner

SociétésPosteFin
CARDIFF ONCOLOGY, INC. Directeur Technique/Scientifique/R&D 22/04/2022
ALX ONCOLOGY HOLDINGS INC. Corporate Officer/Principal 01/05/2021
CTI BIOPHARMA CORP. Directeur Technique/Scientifique/R&D 01/02/2019
Corporate Officer/Principal 01/01/2007
SEAGEN INC. Directeur Technique/Scientifique/R&D -
Voir l'expérience en détail de Katherine Ruffner

Formation de Katherine Ruffner

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

81

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

  1. Bourse
  2. Insiders
  3. Katherine Ruffner
🔇